FDA Inspection
Kyowa Hakko Bio Co., Ltd.Kyowa Hakko Bio Co., Ltd. – FDA Inspection, Sep 8, 2017
Record Details
This FDA Inspection record concerns Kyowa Hakko Bio Co., Ltd., with an inspection on September 8, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- Milva E. Melendez Perales (Issuing Officer)
View Company Profile
ID · aaef8d30-03c0-4dcd-8173-9f89a40add41
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1031649
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Kyowa Hakko Bio Co., Ltd.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 20, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 15, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 8, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 20, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 27, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Kyowa Hakko Bio Co., Ltd.
- FDA Inspection 1253956 - 2024-09-20
- FDA Inspection 1168226 - 2022-04-15
- FDA Inspection 1111871 - 2019-11-08
- FDA Inspection 873726 - 2014-03-20
- FDA Inspection 753000 - 2011-10-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.